Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)
Close on Nov 17, 2026Market cap $37.82MP/E –Yield –
Elutia profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Elutia's profit margin for the twelve months ending Jun 30, 2026 was 426.9%. For fiscal 2025 it was 434.2%, against -372.9% the year before. The highest annual figure on record is 434.2% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 434.2% | +807.1 |
| FY2024 | Dec 31, 2024 | -372.9% | −220.7 |
| FY2023 | Dec 31, 2023 | -152.2% | −14.2 |
| FY2022 | Dec 31, 2022 | -137.9% | −85.5 |
| FY2021 | Dec 31, 2021 | -52.4% | −1.3 |
| FY2020 | Dec 31, 2020 | -51.1% | −23.3 |
| FY2019 | Dec 31, 2019 | -27.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -315.0% | +34.8 |
| Q1 FY2026 | Mar 31, 2026 | -239.9% | −106.6 |
| Q4 FY2025 | Dec 31, 2025 | 2164.2% | +2486.0 |
| Q3 FY2025 | Sep 30, 2025 | -116.4% | −151.5 |
| Q2 FY2025 | Jun 30, 2025 | -349.8% | +98.1 |
| Q1 FY2025 | Mar 31, 2025 | -133.3% | +135.5 |
| Q4 FY2024 | Dec 31, 2024 | -321.8% | −163.2 |
| Q3 FY2024 | Sep 30, 2024 | 35.1% | +194.2 |
| Q2 FY2024 | Jun 30, 2024 | -447.9% | −280.7 |
| Q1 FY2024 | Mar 31, 2024 | -268.8% | −144.1 |
| Q4 FY2023 | Dec 31, 2023 | -158.5% | −84.2 |
| Q3 FY2023 | Sep 30, 2023 | -159.1% | −88.2 |
| Q2 FY2023 | Jun 30, 2023 | -167.2% | −83.8 |
| Q1 FY2023 | Mar 31, 2023 | -124.7% | −52.3 |
| Q2 FY2022 | Jun 30, 2022 | -74.4% | −54.7 |
| Q1 FY2022 | Mar 31, 2022 | -70.9% | −31.6 |
| Q4 FY2021 | Dec 31, 2021 | -83.5% | −40.5 |
| Q3 FY2021 | Sep 30, 2021 | -72.4% | −15.2 |
| Q2 FY2021 | Jun 30, 2021 | -19.6% | +40.7 |
| Q1 FY2021 | Mar 31, 2021 | -39.3% | +6.9 |
| Q4 FY2020 | Dec 31, 2020 | -43.0% | −19.9 |
| Q3 FY2020 | Sep 30, 2020 | -57.2% | −29.3 |
| Q2 FY2020 | Jun 30, 2020 | -60.4% | – |
| Q1 FY2020 | Mar 31, 2020 | -46.2% | – |
| Q4 FY2019 | Dec 31, 2019 | -23.1% | – |
| Q3 FY2019 | Sep 30, 2019 | -27.9% | – |
See a number that looks wrong?